FNAB cytology of extra-cranial metastasis of glioblastoma multiforme may resemble a lung primary: A diagnostic pitfall by Chivukula, Mamatha et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
CytoJournal
Open Access Case Report
FNAB cytology of extra-cranial metastasis of glioblastoma 
multiforme may resemble a lung primary: A diagnostic pitfall
Mamatha Chivukula*1, HE Dincer2, Julie A Biller2, Hendrikus G Krouwer3, 
Grant Simon1 and Vinod Shidham1
Address: 1Departments of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA, 2Pulmonary and Critical Care Medicine, Medical College 
of Wisconsin, Milwaukee, WI, USA and 3Neurology and Neurosurgery; Medical College of Wisconsin, Milwaukee, WI, USA
Email: Mamatha Chivukula* - mchivukula@mail.magee.edu; HE Dincer - erhan_dincer@yahoo.com; Julie A Biller - jbiller@mcw.edu; 
Hendrikus G Krouwer - hkrouwer@mcw.edu; Grant Simon - gsimon@mcw.edu; Vinod Shidham - vshidham@mcw.edu
* Corresponding author    
Glioblastoma multiformeFine needle aspiration biopsy cytologyFNAlung tumor
Abstract
Background: As extra-cranial metastasis of glioblastoma multiforme (GBM) is rare, it may create
a diagnostic dilemma especially during interpretation of fine needle aspiration biopsy (FNAB)
cytology.
Case presentation: We present transbronchial FNAB findings in a 62-year-old smoker with lung
mass clinically suspicious for a lung primary. The smears of transbronchial FNAB showed groups of
cells with ill-defined cell margins and cytological features overlapping with poorly differentiated
non-small cell carcinoma. The tumor cells demonstrated lack of immunoreactivity for cytokeratin,
thyroid transcription factor-1, and usual neuroendocrine markers, synaptophysin and
chromogranin in formalin-fixed cellblock sections. However, they were immunoreactive for the
other neuroendocrine immunomarker, CD56, suggesting neural nature of the cells. Further
scrutiny of clinical details revealed a history of GBM, 13 months status-post surgical excision with
radiation therapy and systemic chemotherapy. The tumor recurred 7 months earlier and was
debulked surgically and with intra-cranial chemotherapy. Additional evaluation of tumor cells for
glial fibrillary acidic protein (GFAP) immunoreactivity with clinical details resulted in final
interpretation of metastatic GBM.
Conclusion: Lack of clinical history and immunophenotyping may lead to a diagnostic pitfall with
possible misinterpretation of metastatic GBM as poorly differentiated non-small cell carcinoma of
lung in a smoker.
Background
Glioblastoma multiforme (GBM) represents extreme ana-
plasia in astrocytic tumors. Similar to other CNS tumors,
the extra-cranial metastasis of GBM is rare and is usually
observed after the tumor has infiltrated the dural veins,
the cranium, the extra-cranial soft tissue, or more fre-
quently after the tumor debulking surgery for a recurrent
tumor [4].
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A literature search revealed only a few case reports of
extra-cranial metastasis of primary GBM to various organs
such as spleen [5], skin [8], heart [7], bone [6], cervical
lymph nodes [9,11] and lung [10,12-14]. In all these cases
the metastases occurred after the resection of primary
intra-cranial tumor with an average time interval of 10
months. Only one case of a spontaneous metastasis of pri-
mary GBM to lungs is reported [13]. The diagnosis in most
cases was based on biopsy and immunophenotyping with
glial fibrillary acidic protein (GFAP).
Since the metastasis of GBM is rare, cytopathological
interpretation for its differentiation from other tumors
may be challenging. Correct interpretation for origin of
the tumor is important in rendering a proper clinical man-
agement. We report a case in which optimum clinical his-
tory and immunohistochemical evaluation played a
crucial role in preventing a diagnostic pitfall of misinter-
preting FNAB cytology of lung mass in a smoker.
Case presentation
A 62-year-old male presented with shortness of breath for
one week. He had a smoking history of 10 pack-years [1
pack per day, per year, for 10 years]. The X-ray chest
revealed a large pleural effusion with suggestion of a mass
in the right upper lobe of lung (RUL) with massive hilar
lymphadenopathy. The left lung parenchyma was normal
and the pulmonary vasculature was not congested. A com-
puterized tomography scan of the chest confirmed a mass
in RUL.
Clinically, the tumor was considered as lung primary and
pulmonary consult was requested. Bronchoscopy of RUL
revealed an irregular friable mucosa. A transbronchial
FNAB of the RUL mass was performed with other
evaluations.
The patient had previous history of GBM in the right
occipital area 13 months ago for which he underwent ini-
tial surgical excision with radiation therapy and systemic
chemotherapy. The tumor recurred after 6 months for
which he underwent extensive debulking and placement
of gliadel wafers (BNCU-impregnated wafers).
Methods
Cytomorphological features on adequacy evaluation of
transbronchial FNAB smears of the RUL mass were con-
sistent with poorly differentiated non-small cell tumor.
Additional material for cellblock was recommended for
elective immunophenotyping of tumor cells.
Other evaluations included an endobronchial biopsy
from RUL, bronchoalveolar lavage of anterior segment of
RUL for cytology, and thoracocentesis of right pleural
effusion for cytology.
Results
Cytopathological findings of transbronchial FNAB of the 
mass
The smears of the fine needle aspirates were relatively cel-
lular with cohesive groups of tumor cells showing mild
pleomorphism. The cells had cyanophilic scant cytoplasm
with indistinct cell borders (Figure-1). The hyperchro-
matic nuclei showed powdery to clear chromatin with
small but distinct nucleoli. Initial cytological differential
diagnosis included poorly differentiated non-small cell
carcinoma, paraganglioma, lymphoma, melanoma, and
non-neoplastic lesion such as granuloma with addition of
metastatic GBM after considering the history of surgical
intervention for recurrent GBM.
As the smears were relatively cellular with significant pro-
portion of tumor cell groups showing hyperchromasia
and pleomorphism, granuloma could be excluded even
with cytomorphological evaluation. However, a few
groups without significant pleomorphism and without
admixture with large tumor cells demonstrated overlap-
ping morphological features with granuloma (Figure-2).
In these groups, the cells showed ill-defined cytoplasm
with slightly elongated, overlapping, oval nuclei. Occa-
sional lymphocytes mixed with these cell groups were
present, but multinucleated giant cells were absent.
Other malignant lesions in the differential diagnosis,
except lymphoma, were relatively difficult to exclude by
morphology alone. The cohesive tumor cells with clear to
dusty chromatin and significant pleomorphism did not
favor lymphoma. The nucleoli were relatively less promi-
nent and did not favor melanoma and large cell carci-
noma of lung. Paragaglioma could not be excluded
morphologically except lack of Zellballen pattern (diffi-
cult to be evaluated cytologically) in the cellblock
sections.
Immunophenotyping of tumor cells was performed on for-
malin-fixed paraffin-embedded cellblock sections (Table
1).
The tumor cells were non-immunoreactive for cytokeratin
7, cytokeratin 20, cocktail of cytokeratin AE1/AE3 – Cam
5.2, thyroid transcription factor (TTF-1), leucocyte com-
mon antigen (LCA, CD45), and MART-1. They were also
non-immunoreactive for neuroendocrine immunomark-
ers, chromogranin and synaptophysin. Non-immunore-
activity for cytokeratin (Figure-3b) ruled out poorly
differentiated carcinoma including lung primary, LCA
non-immunoreactivity (Figure-3c) ruled out lymphoma
and granuloma, nonimmunoreactivity for chromogranin
and synaptophysin ruled out paraganglioma, and MART-
1 non-immunoreactivity (Figure-3d) ruled out
melanoma.CytoJournal 2005, 2:9 http://www.cytojournal.com/content/2/1/9
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Cohesive groups of tumor cells showed mild pleomorphism Figure 1
Cohesive groups of tumor cells showed mild pleomorphism. The cells had cyanophilic scant cytoplasm with indistinct cell bor-
ders with morphological features overlapping with poorly differentiated carcinoma.
A few groups (a through d) did not show pleomorphism but showed occasional lymphocyte (arrowheads in e & f) admixed  with the tumor cells demonstrating ill-defined cell borders superficially resembling a granuloma Figure 2
A few groups (a through d) did not show pleomorphism but showed occasional lymphocyte (arrowheads in e & f) admixed 
with the tumor cells demonstrating ill-defined cell borders superficially resembling a granuloma. However, pleomorphic cells 
(arrows in e & f) were not uncommon in this relatively cellular specimen.
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However, the tumor cells were immunoreactive for CD56
(Figure-3e), consistent with neural differentiation. Based
on the past clinical history of recent surgical intervention
for recurrent GBM, demonstration of immunoreactivity
for GFAP (Figure-3f) confirmed the diagnosis of meta-
static GBM. Previously resected GBM demonstrated com-
parable morphology and immunoprofile (Figure-4)
Endobronchial biopsy
Endobronchial biopsy was negative for tumor.
Table 1: Immnophenotype of tumor cells.
S.No. Immunomarker Antibody (Clone, source, dilution) Antigen retrieval (Pre-treatment of sections) Immunoreactivity 
pattern of tumor cells
1 Cytokeratin Dako, 34BE12, 1:300 for 30 mts Proteinase,-K for 4 mts Non-immunoreactive
2 Cytokeratin 7 Dako, OVTL12/30, 1:100 for 30 mts PH 6.0 at 98 C for 35 mts Non-immunoreactive
3 Cytokeratin 20 Dako, Ks20.8, 1:300 for 30 mts Proteinase, -K for 4 mts Non-immunoreactive
4 TTF-1 Dako, 8G7G3/1, 1:150 for 20 mt Heat DAKO, PH 6.0 for 35 mts Non-immunoreactive
5 LCA Dako, PD7/26/16 and 2B11, 1:200 for 30 mts Proteinase, -K for 4 mts Non-immunoreactive
6 MART-1 SIGNET, M2-7C10 1:600 for 30 mts Heat, PH6.0 for 35 mts, 1:500 for 35 mts Non-immunoreactive
7 Chromogranin Novocastra, LK2H10, 1:600 for 30 mts HeatPH 6.0 for 1:600 for 35 mts Non-immunoreactive
8 Synaptophysin Dako, 1:100 for 30 mts HeatPH 6.0 for 35 mts, 1:200 for 30 mts Non-immunoreactive
9 CD56 Novocastra, 186, 1:100 for 45 mts Heat DAKO, PH 6.0 for 30 mts, cool 20 mts Immunoreactive
Representative immunoprofile of tumor cells on cellblock sections (see also table 1) a. H&E; b Figure 3
Representative immunoprofile of tumor cells on cellblock sections (see also table 1) a. H&E; b. Cytokeratin (non-immunoreac-
tive); c. LCA (non-immunoreactive); d. MART-1 (non-immunoreactive); e. CD56 (immunoreactive); f. GFAP 
(immunoreactive).
a
f e d
b c
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Cytopathology of other material
The bronchoalveolar lavage and pleural fluid cytology
were negative for malignant cells.
Discussion
GBM is by far the most common high-grade glioma repre-
senting anaplastic spectrum of fibrillary and diffuse cyto-
plasmic astrocytoma [2]. It shows marked cellularity,
pleomorphism, many mitotic figures, necrosis, and vascu-
lar proliferation [2]. The tumor presents usually in the cer-
ebral hemispheres in adults and in brain stem in children.
Despite the external-beam radiotherapy and surgery, the
median survival for GBM is relatively short (approxi-
mately 12 months) [2].
A very few reports describing the cytological features of
GBM are found in the literature [9,11,19]. Of the CNS
tumors, glioblastoma multiforme is a relatively easy to
recognize cytologically as malignant. A review article
described cytopathology of various CNS tumors including
15 cases of GBM [19].
However when GBM is sampled from the extra-cranial
sites such as lung or lymph node, a differential diagnosis
from other tumors may be challenging. Cytologically the
smears of GBM show large, spindle to oval, hyperchro-
matic and pleomorphic nuclei. A fibrillary or necrotic
background is also noticed in some of these tumor cells of
GBM may be recognizable as astrocytic [1]. But due to the
marked pleomorphism of cohesive groups of tumor cells
with frequent mitoses, the recognition of GBM from other
poorly differentiated tumors may be challenging.
The cell borders of the cohesive tumor cells in the present
case were predominantly indistinct with differential diag-
nosis of poorly differentiated carcinoma, melanoma, par-
aganglioma, sarcoma, and even lymphoma may be
challenging. In the smears with scant cellularity with
absence of significant pleomorphism, some groups may
resemble granuloma. The smears showing cytoplasmic
type of astrocytic tumor cells with well-defined cytoplasm
with distinct cell margins may particularly resemble
poorly differentiated carcinoma, lymphoma, and
melanoma [1].
The tumor cells of GBM are immunoreactive for GFAP and
Vimentin [2]. Vimentin immunoreactivity is non-diag-
nostic due to significant overlap with other lesions in the
differential diagnosis of poorly differentiated tumors.
Immunoreactivity of tumor cells for GFAP confirms glial
differentiation. Generally the astrocytic type of cells shows
immunoreactivity for GFAP, but small-undifferentiated
cells are often weakly immunoreactive or non-immunore-
active [2]. It is unusual for the gliomas to be positive for
epithelial markers such as cytokeratin, thus differentiating
them from carcinomas. Although rare, 4% of GBMs may
be immunoreactive for cytokeratin, but this is usually
weak and focal [2].
Histomorphology and GFAP immunoreactivity of previously resected GBM Figure 4
Histomorphology and GFAP immunoreactivity of previously resected GBM.
a HE 20X b HE 40X c GFAP 40XCytoJournal 2005, 2:9 http://www.cytojournal.com/content/2/1/9
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Gliosarcoma is other rare subtype of GBM, which shows a
characteristic biphasic appearance, consisting of GBM
component admixed with sarcomatous elements [17,18].
Extra-cranial metastases of gliosarcoma with sarcomatoid
component have been reported in 17 cases (mostly
imprint smears with one case as fine needle aspiration
biopsy cytology; 7 cases in lung, 6 cases in liver, 2 cases in
lymph nodes, 1 in adrenal gland, and 1 in vertebral body)
[18].
Although rare, extra-cranial metastasis of GBM may be
observed after craniotomy and trephination procedures
for initial GBM or more frequently after tumor debulking
surgery for a recurrent tumor. A case of metastatic seeding
along the needle biopsy tract of a GBM has been reported
[16]. Such metastases are attributed to the infiltration of
tumor cells into surrounding tissue and extra cranial
blood vessels.
Presentation of extracranial metastasis of GBM as a single
mass in lung may suggest a differential diagnosis of a
poorly differentiated carcinoma [9]. Small cell carcinoma
cytologically shows cohesive groups of hyperchromatic,
usually small cells, with scant cytoplasm without signifi-
cant pleomorphism. Rare case reports of a metastatic
glioblastoma to cervical lymph node resembling small
cell carcinoma have been described in literature [9,11]. In
the present case, the small cell carcinoma was not a signif-
icant differential diagnosis, as it demonstrated pleomor-
phism with dusty chromatin and small but visible
nucleoli with possibility of poorly differentiated non-
small cell carcinoma. Mitoses and apoptotic cells are fre-
quent in small cell carcinoma with many fragile nuclei
disrupted as strings of DNA material in the background.
The nuclei may be round to oval with 'salt and pepper'
chromatin without perceptible nucleoli. Nuclear molding
with zig-saw puzzle-like accommodation of nuclear
shapes with adjacent nuclei may be present due to scant
cytoplasm and delicate nuclear membranes. The tumor
cells in this case were non-immunoreactive for cytokerat-
ins and neuroendocrine markers such as chromogranin
and synaptophysin, further ruling out the possibility of
poorly differentiated carcinoma of lung, both small cell
and non-small cell type.
The collection of epitheliod histiocytes in a granuloma
show elongated oval carrot shaped nuclei, which usually
are not hyperchromatic. The indistinct cell borders impart
syncitial appearance to the group. These epitheliod cells
are usually admixed with small lymphocytes and may be
associated with multinucleated giant cells. In the present
case, a few groups of cells did not show pleomorphism
but showed occasional lymphocyte admixed with the
tumor cells demonstrating ill-defined cell borders superfi-
cially resembling a granuloma (Figure-2). In the present
case, the granuloma could be ruled out even morpholog-
ically, as the smears were relatively cellular with signifi-
cant proportion of tumor cells showing hyperchromatic
and pleomorphic nuclei. In addition, the cells were non-
immunoreactive for LCA, which is usually immunoex-
pressed in epitheloid cells of granuloma.
A paraganglioma shows tumor cells with ill-defined cell
borders and nuclei with small nearly visible red nucleoli.
The tumor cells may show pleomorphism. The cytoplasm
is wispy and finely granular with frayed cell margins. Pres-
ence of bare nuclei is frequent [3]. Zellballen arrangement
may be observed in cellblock sections. Although, some of
the cytomorphological features overlapped, the tumor
cells in this case were non-immunoreactive for neuroen-
docrine markers such as chromogranin and synapto-
physin in cellblock sections without Zellballen
arrangement excluding paraganglioma.
Individual morphological features of melanoma includ-
ing prominence of nucleoli, nuclear pseudoinclusions,
cytoplasmic melanin pigment, and frequent binucleation
with 'demon-eye' nuclei were absent in the present tumor.
As melanoma is a great mimicker with diverse morpho-
logical patterns, it was ruled out with non-immunoreac-
tivity of these tumor cells for melanoma marker such as,
MART-1.
The cells in high-grade large cell lymphomas may show
heterogenous population of medium to large pleomor-
phic non-cohesive cells with clumped nuclear chromatin.
The cell borders of singly scattered lymphoma cells are
usually distinct [3]. The tumor cells in the present case
showed powdery to clear chromatin with cohesive groups
of cells without distinct cell borders. They were non-
immunoreactive for LCA further ruling out lymphoma.
Conclusion
Due to the rarity of event, in the absence of proper clinical
correlation, extracranial metastases of GBM may be misdi-
agnosed. In the present case, although the cytomorpho-
logical features resembled poorly differentiated non-small
cell carcinoma of lung, they were not convincing enough
to suggest a specific diagnosis. Further evaluation, includ-
ing clinical history of previously resected GBM with
recurrence and immunophenotyping with appropriate
immuno panel, avoided the pitfall leading to proper inter-
pretation of the lung mass in this case as metastatic GBM.
List of abbreviations
BNCU, Bi chloroethylnitrosourea, (Chemotherapy drug);
CNS, central nervous system; FNAB, Fine needle aspira-
tion biopsy; GBM, Glioblastoma multiforme; GFAP, glial
fibrillary acidic protein; LCA, leucocyte common antigen;
RUL, right upper lobe of lung.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
CytoJournal 2005, 2:9 http://www.cytojournal.com/content/2/1/9
Page 7 of 7
(page number not for citation purposes)
Authors' contributions
1. (MC) Cytology fellow of the case, collected all the data,
participated in cytological evaluation and drafting of
manuscript.
2. (HD) Pulmonary fellow of the case and reviewed the
manuscript.
3. (JB) Pulmonologist of the case and reviewed the
manuscript.
4. (HK) Neuro-oncologist of the case and reviewed the
manuscript.
5. (GS) Neuro-surgeon of the case and reviewed the
manuscript.
6. (VS) Cytologist of the case, conceptual organization
and manuscript writing.
Consent
This case report is published after consent by the spouse
of the deceased patient.
Acknowledgements
CytoJournal thanks Yener Erozan, M.D. (yerozan@jhmi.edu), Professor, 
Dept. of Pathology, The Johns Hopkins Hospital, 406 Pathology Building 2: 
600 North Wolfe Street, Baltimore, MD21287-6940 for organizing and 
completing the peer-review process for this manuscript as its Academic 
Editor."
References
1. Aspiration cytology, the art and science of Cytopathology,
RichardM Demay.  .
2. Atlas of Tumor pathology, Tumors of the Central nervous
system, P. Burger, B. Scheithauer, AFIP, third series, AFIP
fascicle 10.  .
3. Atkinson Barbara : Atlas of Diagnostic cytopathology.  2nd edi-
tion. Saunders . 
4. Terheggen HG, Muller W: Extra cerebrospinal metastasis in
glioblastom a. Case Report and review of literature.  Eur J
Pediatrics 124(2):155-64. 1977 jan 26
5. Tamiya YT, Meguro T, Ichikawa T, Sato Y, Date I, Nakashima H,
Ohomoto T: Glioblastoma with metastasis to spleen – case report,
NeurologicaMedico-Chirurgica 2003, 43(9):452-6.
6. Sadik AR, Port R, Garfinkel B, Bravo J: Extracranial metastasis of cere-
bral Glioblastoma multiforme: Case report, Neurosurgery 1984,
15(4):549-51.
7. Hata N, Katsuta T, Inoue T, Arikawa K, Yano T, Takeshita M, Iwaki T:
Extra-cranial metastasis of glioblastoma to lung and heart with a histological
resemblence to small cell carcinoma of the lung: an autopsy case: No
Shinkei Geka-neurological surgery 2001, 29(5):438-8.
8. Figuera P, Lupton JR, Remington T, Olding M, Jones RV, Sekhar LN,
Sulica VI: Cutaneous metastasis from an intracranial glioblas-
toma multiforme.  J Am Acad Dermatol 2002, 46(2 (Part
1)):297-300.
9. Campora RG, Salverri CO, Ramirez FV, Villadiego MS, Davidson HG:
Metastatic Glioblastoma multiforme in cervical lymph
nodes.  Report of a case with diagnosis by fine needle aspiration, Acta
cytologica 1993, 7(6):938-42.
10. Granjon O, Lange F, Aurtheir FJ, Lebragy F: Pulmonary metastases of
glioblastoma, revue des maladies respiratoires 1995, 12(5):489-91.
11. Al-Rikabi AC, Al-Sohaibani MO, Jamjoom A, Al-rayess MM: Meta-
static deposits of a high-grade malignant glioma in cervical
lymphnode diagnosed by fine-needle aspiration cytology-
case report and literature review.  Cytopathology 1997,
8(6):421-7.
12. Laraqui L, Amarti A, Zouaidia F, Maher M, Kettani F, Saidi A: Pulmo-
nary metastasis from a gliblastoma. A case report (Article in French), Rev
Pneumol Clin, 2001 Jin 2001, 57(3):225-8.
13. Chung YH, Wong SL, Huang HY: Endobronchial metastasis of glioblast-
oma multiforme diagnosed by fiber-optic bronchoscopic biopsy, Journal of
Formosan medical Association 1999, 98(2):133-5.
14. Greif J, Horovitz M, Marmor S: Pleuropulmonary metastasis
from an intracranial glioblastoma.  Lung cancer 1998,
20(2):135-7.
15. Vural G, Hagmar B, Walaas L: Extra-cranial metastasis of glioblastoma
multiforme diagnosed by fine-needle aspiration: a report of 2 cases and a
review of literature, Diagnostic cytopathology 1996, 15(1):60-5.
16. Steinmetz P, Barnett GH, Chidel MA, Suh JH: Metastatic seeding
of the stereotactic biopsy tract in glioblastoma multiforme:
a case report and review of the literature.  J neuro onco 2001,
55(3):167-71.
17. Parwani A, Berman D, Burger P, Ali S: Gliosarcoma: Cytopatho-
logic characteristics on Fine-needle aspiration (FNA) and
Intraoperative  Touch imprint.  Diagnostic Cytopathology 2004,
30(2):77-81.
18. Yokoyama H, Ono H, Mori K, kishikawa M, kihara M: Extracranial
metastasis of Glioblastoma with sarcomatous component, Surgical
Neurology 1985, 24:641-5.
19. Liwnicz B, Henderson K, Masukawa T, Smith R: Needle aspiration cytol-
ogy of intracranial lesions, Acta cytologica 1982, 26(6):779-86.